Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer. JAMA. 2017;317:2532.
Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, et al. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014;65:1046–55.
Article PubMed PubMed Central Google Scholar
Ebrahimizadeh W, Guérard KP, Rouzbeh S, Bramhecha YM, Scarlata E, Brimo F, et al. Design and development of a fully synthetic multiplex ligation-dependent probe amplification–based probe mix for detection of copy number alterations in prostate cancer formalin-fixed, paraffin-embedded tissue samples. J Mol Diagn. 2020;22:1246–63.
Article CAS PubMed Google Scholar
Liu W, Hou J, Petkewicz J, Na R, Wang C, Sun J, et al. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression. Prostate. 2020;80:1253–62.
Article CAS PubMed Google Scholar
Fu X, Shi Y, Ma J, Zhang K, Wang G, Li G, et al. Advances of multiplex ligation-dependent probe amplification technology in molecular diagnostics. Biotechniques. 2022;73:205–13.
Ebrahimizadeh W, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Patel PG, et al. A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients. Br J Cancer. 2023;128.
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11–22.
Article CAS PubMed PubMed Central Google Scholar
Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study. EBioMedicine. 2015;2:1133–44.
Article CAS PubMed PubMed Central Google Scholar
Espiritu SMG, Liu LY, Rubanova Y, Bhandari V, Holgersen EM, Szyca LM, et al. The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell. 2018;173:1003–13.e15.
Article CAS PubMed Google Scholar
Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. Lancet Oncol. 2014;15:1521–32.
Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33:272–7.
留言 (0)